sthma
common
chronic
respiratori
disord
childhood
affect
local
children
asthma
exacerb
result
hospit
account
major
fraction
total
cost
asthma
care
societi
prospect
epidemiolog
studi
show
childhood
asthma
exacerb
associ
viral
upper
respiratori
tract
infect
rti
among
respiratori
virus
human
rhinoviru
hrv
infect
preced
mani
asthma
exacerb
children
infl
uenza
virus
also
account
substanti
morbid
eg
annual
outpati
visit
per
children
children
asthma
chronic
medic
condit
respiratori
syncyti
viru
rsv
anoth
major
pathogen
caus
asthma
exacerb
background
asthma
exacerb
white
children
associ
viral
upper
respiratori
infect
rel
import
differ
respiratori
pathogen
relev
microbiolog
data
asian
children
unclear
studi
elucid
epidemiolog
respiratori
infect
hong
kong
children
asthma
exacerb
method
total
children
age
year
asthma
exacerb
control
stabl
asthma
recruit
sever
asthma
exacerb
assess
accord
global
initi
asthma
guidelin
subject
age
year
older
perform
exhal
nitric
oxid
spirometr
measur
nest
multiplex
polymeras
chain
reaction
use
detect
differ
respiratori
pathogen
result
respiratori
pathogen
detect
subject
presenc
respiratori
pathogen
associ
asthma
exacerb
odd
ratio
ci
p
specifi
calli
human
rhinoviru
hrv
infect
common
among
children
asthma
exacerb
ci
p
pathogen
coinfect
associ
asthmat
attack
none
respiratori
infect
associ
sever
asthma
exacerb
p
peak
hrv
season
winter
viru
detect
children
asthma
exacerb
conclus
respiratori
viral
infect
commonli
found
children
asthma
exacerb
hrv
import
pathogen
patient
respiratori
viral
infect
trigger
factor
asthma
exacerb
correl
sever
abbrevi
feno
fraction
exhal
nitric
oxid
concentr
hbov
human
bocaviru
hcov
human
coronaviru
hmpv
human
metapneumoviru
hrv
human
rhinoviru
ic
inhal
corticosteroid
npa
nasopharyng
aspir
odd
ratio
pcr
polymeras
chain
reaction
rsv
respiratori
syncyti
viru
rti
respiratori
tract
infect
year
defi
nitiv
diagnosi
asthma
may
diffi
cult
differenti
acut
bronchiol
asthma
younger
children
patient
receiv
antimicrobi
agent
eg
neuraminidas
inhibitor
ribavirin
macrolid
within
week
studi
also
exclud
sever
asthma
exacerb
classifi
ed
accord
global
initi
asthma
guidelin
infect
defi
ned
detect
respiratori
pathogen
nest
multiplex
pcr
assay
primari
outcom
differ
detect
rate
respiratori
pathogen
children
asthma
acut
exacerb
control
ie
stabl
asthma
secondari
outcom
consist
differ
clinic
sever
asthma
exacerb
lung
function
paramet
fraction
exhal
nitric
oxid
concentr
feno
relat
patient
differ
respiratori
pathogen
clinic
research
ethic
committe
univers
approv
studi
follow
inform
written
consent
subject
clinic
assess
follow
feno
spirometr
measur
subject
year
age
older
underw
onlin
feno
measur
use
chemiluminesc
analyz
siever
boulder
co
accord
intern
guidelin
mean
feno
three
plateau
valu
record
feno
measur
within
h
hospit
children
acut
asthma
clinic
visit
stabl
patient
former
group
allow
commenc
system
corticosteroid
clinic
indic
prior
feno
would
uneth
withhold
treatment
studi
follow
feno
perform
spirometri
compact
ii
vitalograph
buckingham
uk
measur
fev
fvc
fev
fvc
accord
local
infect
control
polici
nasopharyng
aspir
npa
collect
negativepressur
isol
room
deep
nasal
swab
obtain
altern
situat
isol
facil
unavail
specimen
put
immedi
viral
transport
medium
kept
transport
viral
rna
dna
extract
day
collect
purelink
viral
rna
dna
mini
kit
invitrogen
carlsbad
ca
rna
extract
convert
cdna
revers
transcriptas
superscript
iii
revers
transcriptas
invitrogen
dna
cdna
use
immedi
nest
multiplex
pcr
respiratori
pathogen
describ
previous
tabl
onlin
supplement
summar
sequenc
amplicon
size
outer
inner
set
pcr
primer
briefl
nest
multiplex
pcr
assay
detect
four
pathogen
group
compris
infl
uenza
b
groupspecifi
c
subtyp
c
primer
group
compris
parainfl
uenza
virus
group
compris
rsv
b
hrv
enteroviru
group
compris
sarscov
hmpv
group
compris
pneumonia
c
pneumonia
hbov
adenoviru
fi
rst
second
round
pcr
conduct
l
reaction
mixtur
use
fast
thermal
cycler
appli
biosystem
foster
citi
ca
two
microlit
cdna
use
templat
fi
rst
round
pcr
group
wherea
l
extract
prepar
use
group
second
round
pcr
l
aliquot
fi
rstround
pcr
product
use
templat
tabl
onlin
supplement
summar
pcr
condit
fi
multiplex
nest
pcr
assay
pcr
product
stain
sybr
safe
invitrogen
visual
electrophoresi
agaros
gel
four
correspond
posit
control
one
neg
control
steril
water
sampl
respiratori
virus
human
coronaviru
hcov
human
metapneumoviru
hmpv
common
caus
upper
rti
relat
asthma
exacerb
remain
u
nclear
alland
et
al
develop
system
largescal
molecular
viru
screen
clinic
sampl
base
host
dna
deplet
random
polymeras
chain
reaction
pcr
amplifi
cation
largescal
sequenc
bioinformat
recent
describ
parvoviru
call
human
bocaviru
hbov
identifi
ed
children
lower
rti
relat
asthma
exacerb
uncertain
present
asthma
exacerb
may
also
caus
atyp
bacteria
chlamydophila
pneumonia
oblig
intracellular
respiratori
pathogen
link
asthma
exacerb
children
among
children
hospit
wheez
johnston
detect
respiratori
virus
patient
age
less
month
age
year
asthmarel
symptom
resolv
signifi
cantli
improv
half
adult
patient
asthma
seroposit
c
pneumonia
treat
macrolid
doxycyclin
mycoplasma
pneumonia
detect
pcr
patient
asthma
also
found
upper
airway
secret
patient
stabl
asthma
import
understand
role
differ
respiratori
pathogen
play
precipit
asthmat
attack
order
determin
way
reduc
healthcar
burden
associ
asthmarel
hospit
object
studi
investig
import
differ
respiratori
patho
gen
childhood
asthma
exacerb
delin
epidemiolog
respiratori
pathogen
caus
asthma
exacerb
hong
kong
children
studi
recruit
children
asthma
age
year
diseas
exacerb
receiv
treatment
either
pediatr
ward
outpati
clinic
univers
teach
hospit
januari
februari
inpati
hospit
asthma
exacerb
assess
within
h
hospit
ageand
sexmatch
children
asthma
free
rti
week
longer
seen
allergi
clinic
within
week
children
acut
asthma
recruit
control
asthma
diagnosi
made
accord
british
thorac
societi
criteria
briefl
older
patient
either
hyperrespons
methacholin
show
revers
airfl
ow
limit
wherea
young
children
asthma
three
episod
cough
short
breath
wheez
month
studi
young
patient
also
show
good
respons
bronchodil
studi
select
children
older
includ
group
simultan
order
prevent
pcr
contamin
reagent
prepar
sampl
process
nest
pcr
assay
perform
separ
room
away
amplifi
ed
product
analyz
aerosolresist
pipett
tip
use
throughout
experi
rti
agedepend
tri
match
one
control
per
patient
respect
age
sex
howev
fail
recruit
target
number
control
mani
children
stabl
asthma
rti
symptom
winter
detect
rate
respiratori
pathogen
case
control
analyz
x
fisher
exact
test
sever
asthma
exacerb
feno
spirometr
paramet
analyz
subgroup
differ
pathogen
x
student
test
multivari
logist
regress
use
identifi
respiratori
pathogen
associ
asthma
exacerb
adjust
age
inhal
corticosteroid
ic
treatment
domest
tobacco
smoke
exposur
covari
analys
perform
twotail
use
spss
spss
inc
chicago
il
level
signifi
canc
set
two
hundr
nine
children
asthma
exacerb
includ
patient
hospit
pediatr
ward
six
attend
outpati
clinic
control
stabl
asthma
recruit
tabl
show
characterist
patient
children
asthma
exacerb
younger
control
mainli
inabl
recruit
one
agematch
control
child
asthma
exacerb
similar
proport
patient
two
group
receiv
regular
ic
treatment
suffi
cient
respiratori
sampl
collect
case
control
consist
npa
sampl
nasal
swab
respiratori
pathogen
detect
subject
tabl
summar
distribut
respiratori
pathogen
two
group
patient
presenc
viru
without
atyp
bacteria
associ
asthma
exacerb
p
specifi
calli
hrv
infect
common
among
children
asthma
exacerb
odd
ratio
ci
p
logist
regress
asthma
exacerb
associ
detect
hrv
ci
p
respiratori
viru
ci
p
respiratori
pathogen
ci
p
none
respiratori
pathogen
coinfect
associ
sever
asthma
exacerb
p
age
gender
ic
treatment
affect
detect
respiratori
pathogen
patient
asthma
exacerb
p
tabl
summar
clinic
featur
patient
asthma
exacerb
relat
hrv
infect
respiratori
pathogen
detect
patient
hrv
peak
winter
earli
spring
multiplex
nest
pcr
assay
specifi
c
sensit
convent
method
detect
virus
assay
detect
nucleic
acid
copi
virus
except
enterovirus
compar
report
wide
quot
highthroughput
multiplex
pcr
assay
specifi
calli
nest
pcr
abl
detect
one
cdna
copi
hrv
present
studi
use
method
except
legionella
pneumophila
replac
hbov
investig
infect
caus
asthma
exacerb
hong
kong
children
hrv
infect
also
peak
winter
children
asthma
exacerb
fig
detect
rate
similar
previou
local
studi
lower
publish
white
popul
uncertain
whether
low
hrv
detect
rate
due
limit
pcr
techniqu
less
like
view
previous
note
vitro
result
genuin
low
incid
hrv
infect
hong
kong
children
studi
asian
popul
need
confi
rm
fi
nding
hrv
infect
associ
asthma
exacerb
children
consist
feno
paramet
differ
patient
without
hrv
signifi
cantli
lower
former
group
p
ten
control
hrv
posit
mean
sd
feno
without
hrv
ppb
ppb
respect
p
tabl
summar
relationship
age
differ
respiratori
pathogen
patient
asthma
exacerb
patient
asthma
exacerb
caus
respiratori
virus
younger
without
identifi
abl
viral
infect
p
fi
nding
attribut
mainli
rsv
p
infl
uenza
hmpv
infect
p
age
differ
case
control
group
infect
organ
includ
hrv
coinfect
figur
illustr
season
pattern
hrv
found
patient
throughout
studi
period
peak
winter
novemberdecemb
similarli
control
hrv
autumnwint
septemberoctob
none
hrv
posit
springsumm
marchaugust
low
posit
rate
respiratori
pathogen
subject
preclud
analysi
season
pattern
b
hand
hrv
infect
detect
subject
stabl
asthma
experi
symptom
sign
diseas
exacerb
longitudin
studi
healthi
children
hrv
infect
asymptomat
futur
studi
delin
pathogen
linkag
hrv
worsen
asthma
past
year
impress
advanc
understand
interact
hrv
host
immun
hrv
infect
human
cell
via
ligat
major
group
receptor
intercellular
adhes
molecul
infect
respiratori
epitheli
cell
possibl
macrophag
produc
varieti
proinfl
ammatori
cytokin
chemokin
leukotrien
mediat
turn
attract
differ
infl
ammatori
cell
airway
result
worsen
immunopatholog
increas
bronchial
hyperrespons
observ
patient
asthma
addit
airway
epithelium
patient
asthma
defi
cient
mount
adequ
antivir
respons
hrv
hbov
detect
local
children
hospit
acut
rti
season
distribut
note
septemb
februari
despit
detect
hbov
case
control
associ
asthma
exacerb
present
studi
fi
nding
might
explain
exclus
infant
young
children
increas
risk
hbov
infect
threefi
fth
adult
asthma
exacerb
pneumonia
andor
c
pneumonia
telithromycin
shown
use
treatment
patient
pneumonia
detect
half
patient
asthma
also
upper
airway
secret
patient
chronic
stabl
asthma
hahn
claim
oral
macrolid
effi
caciou
patient
acut
asthma
hand
cunningham
et
al
fail
show
relat
pneumonia
childhood
asthma
exacerb
pneumonia
c
pneumonia
detect
children
asthma
exacerb
similar
observ
patient
stabl
asthma
fi
nding
support
atyp
bacteria
import
pathogen
asthma
exacerb
children
use
macrolid
treat
patient
major
limit
project
relat
studi
power
number
control
much
lower
recruit
case
mainli
casecontrol
match
within
week
possibl
mani
occas
stabl
especi
younger
patient
also
complain
nonspecifi
c
upper
respiratori
symptom
eg
rhinorrhea
block
nose
sore
throat
chang
weather
sampl
size
power
detect
differ
detect
viru
case
control
publish
data
import
hrv
white
popul
childhood
origin
asthma
birth
cohort
total
children
follow
prospect
birth
year
age
hrvassoci
wheez
year
strongest
predictor
asthma
diagnosi
age
year
nearli
children
wheez
hrv
year
subsequ
develop
asthma
two
studi
found
hrv
import
microbiolog
risk
factor
asthma
diagnosi
diseas
exacerb
recent
miller
et
al
report
childhood
asthma
exacerb
associ
novel
group
c
hrv
rather
two
previous
known
phylogenet
group
result
express
mean
sd
includ
data
pathogen
detect
fi
patient
p
betweengroup
comparison
b
p
betweengroup
comparison
c
p
betweengroup
comparison
dr
g
w
k
wong
contribut
subject
recruit
manuscript
prepar
dr
chan
contribut
design
supervis
virolog
investig
particip
manuscript
prepar
financialnonfi
nancial
disclosur
author
report
chest
potenti
confl
ict
interest
exist
companiesorgan
whose
product
servic
may
discuss
articl
margin
power
hrv
infect
graphpad
statmat
san
diego
ca
detect
respiratori
pathogen
rariti
thu
larger
studi
need
delin
possibl
associ
asthma
exacerb
rti
organ
lack
standard
methodolog
hrv
detect
would
also
pose
problem
recent
studi
reveal
hrv
consist
distinct
serotyp
view
degre
phylogenet
heterogen
pcr
primer
design
multiplex
assay
abl
detect
hrv
despit
use
sensit
multiplex
assay
discuss
previous
molecular
approach
detect
virus
would
miss
hrv
cover
pcr
primer
futur
studi
need
adopt
multipl
pcr
primer
specifi
calli
target
mani
hrv
serotyp
possibl
anoth
weak
npa
sampl
collect
subject
wherea
nasal
swab
collect
remain
subject
previous
report
overal
sensit
detect
infl
uenza
parainfl
uenza
rsv
adenoviru
npa
higher
obtain
nasal
swab
local
children
hand
relev
data
hrv
although
subject
npa
sampl
possibl
might
miss
organ
nasal
swab
also
observ
patient
hospit
asthma
exacerb
success
perform
feno
measur
accord
guidelin
tabl
patient
sever
bronchospasm
probabl
breathless
procedur
patient
milder
attack
would
contribut
feno
read
group
addit
substanti
proport
patient
treat
system
corticosteroid
prior
feno
reason
explain
lower
feno
patient
compar
patient
stabl
asthma
conclus
respiratori
virus
atyp
bacteria
detect
half
hong
kong
children
asthma
exacerb
hrv
infect
import
risk
factor
asthma
exacerb
patient
nonetheless
none
pathogen
associ
sever
asthma
exacerb
